Mandatory notification of trade in Hofseth BioCare ASA (HBC)
Ødegård Prosjekt AS, a company owned by appointed CEO and primary insider in
Hofseth BioCare ASA, Jon Olav Ødegård, bought 10.000 shares in Hofseth BioCare
ASA on 11 January 2013 at an average price of NOK 3.55 per share.
Following the transaction, Mr. Ødegård holds 10.000 shares in the company,
corresponding to 0.02% of the total shares outstanding.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.